US watchdog prompts FDA to review information security of active implantables
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration says it will reassess how it evaluates software in medical devices, after a Government Accountability Office report said the agency should pay closer attention to potential information security threats that may affect active implantable medical devices that have wireless capability and use software.